» Articles » PMID: 6167345

Carcinoma-associated Cytostructural Antigenic Alterations: Detection by Lectin Binding

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1981 Jun 15
PMID 6167345
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor cell membrane glycoproteins may be involved in the induction of tumor immunity or in the escape of tumors from immunologic defense mechanisms. Previous investigations have suggested a role for blood group antigens and their precursors, in the generation of the immune response to neoplasia. In this study, 44 benign and malignant breast lesions were examined for the presence of a carbohydrate precursor antigen (T-antigen) of the human blood group system MN. T-antigen was demonstrated using an immunohistochemical technique to detect tissue binding of a plant lectin (PNA) with specificity for T-antigen. Of the 22 benign breast lesions examined, 19 showed T-antigen present along the luminal cytoplasmic membrane and occasionally on intraluminal secretions. T-antigen, as demonstrated by lectin binding, was confined to this region in all benign lesions except one, which also showed cytoplasmic positivity. Malignant breast lesions showed a pattern of T-antigen expression markedly different from that of benign breast tissues. Of 22 breast carcinomas, 17 showed diffuse cytoplasmic T-antigen. Five carcinomas showed no evidence of T-antigen by this technique. These malignancies tended to be the most poorly differentiated when judged by histologic criteria. A possible role for T-antigen in the modulation of the immune response to breast carcinoma is suggested.

Citing Articles

Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.

Heimburg-Molinaro J, Almogren A, Morey S, Glinskii O, Roy R, Wilding G Neoplasia. 2009; 11(8):780-92.

PMID: 19649208 PMC: 2713588. DOI: 10.1593/neo.09504.


Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.

Heimburg J, Yan J, Morey S, Glinskii O, Huxley V, Wild L Neoplasia. 2006; 8(11):939-48.

PMID: 17132226 PMC: 1716011. DOI: 10.1593/neo.06493.


Radioiodinated peanut lectin: a potential radiopharmaceutical for immunodetection of carcinoma expressing the T antigen.

Zabel P, Noujaim A, Shysh A, Bray J Eur J Nucl Med. 1983; 8(6):250-4.

PMID: 6873103 DOI: 10.1007/BF00522515.


Binding of lectins to human mammary tumors: ultrastructural study.

Calafat J, Janssen H Breast Cancer Res Treat. 1984; 4(3):169-79.

PMID: 6487820 DOI: 10.1007/BF01806482.


Peanut lectin histochemistry of 120 mammary carcinomas and its relation to tumor type, grading, staging, and receptor status.

Bocker W, Klaubert A, Bahnsen J, Schweikhart G, Pollow K, Mitze M Virchows Arch A Pathol Anat Histopathol. 1984; 403(2):149-61.

PMID: 6202056 DOI: 10.1007/BF00695231.